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One more mechanism for regulating surface expres-
sion of MHC class II proteins in dendritic cells (an
important process that regulates both tolerance and
immunity) has been uncovered, polyubiquitination of
Lys225 in the intracytoplasmic region and subsequent
endocytosis and proteolysis (Omura-Hoshino et al.,
2006; van Neil et al., 2006; Shin et al., 2006).
A hallmark difference that defines the maturation state
of dendritic cells (DCs) is the surface amount of MHC
class II proteins and ligands for T cell costimulatory
molecules. Immature DCs generally express a low
amount of MHC class II proteins (either empty or loaded
with invariant chain and self antigens), whereas mature
DCs, upon foreign-antigen uptake, express high
amounts of MHC class II heterodimers loaded with im-
munogenic peptides (Figure 1). These quantitative and
qualitative differences in surface phenotype correlate
with the capacity of the immature DC to interact with
naive T cells and induce tolerance as opposed to the
mature DC, which stimulates strong immunity. Consid-
ering the immunological importance related to the stage
of DC maturity, it is only natural that considerable effort
has been invested during the last few years so that the
biological mechanisms controlling cellular trafficking
of MHC class II molecules in relationship to the surface
quantitative changes observed during DC maturation
could be understood.
Mechanisms accounting for regulation of MHC class
II surface expression in the maturing DC include differ-
ences mostly at the posttranslational level because at
the transcriptional and translational level, CIITA, the
master regulator of MHC class II transcription, is rapidly
inactivated by a variety of different proinflammatory
stimuli, and the synthesis of MHC class II mRNA is rap-
idly shut down upon DC maturation (Landmann et al.,
2001). In immature DCs, peptide-loaded surface MHC
class II molecules recycle quickly compared to mature
cells, which display long-lived surface MHC class II
peptide complexes (Cella et al., 1997; Villadangos
et al., 2001). Altogether these studies give the impres-
sion that in immature DCs, the majority of MHC class
II molecules is retained inside the cells, whereas in ma-
ture cells they are mostly expressed at the plasma
membrane.
Three recently published papers shed new light on the
fast surface recycling mechanism and the associated
endosomal retention of MHC class II proteins in imma-
ture DC. Ohmura-Hoshino et al. (2006) reported an E3
ubiquitin ligase (c-MIR), which is part of the mammalian
E3 MARCH family (membrane-associated RING-CH
proteins) that targets lysine 225 on the cytoplasmic tail
of the MHC class II b chain. Similar results on the ubiq-
uitination of MHC class II b chain Lys 225 are also re-
ported by van Niel et al. (2006) in this issue of Immunityand by Shin et al. (2006). All authors indicate that by
adding a few (3–5) ubiquitin residues to the b chain, sur-
face MHC class II proteins are rapidly internalized to en-
dosomal compartments (Figure 1). At any given time,
the amount of ubiquitinated proteins is only a fraction
of the total MHC class II molecules because ubiquitin
is quickly removed upon internalization or delivery to
multivesicular endosomes (van Niel et al., 2006; Shin
et al., 2006). Whether a fraction of MHC class II proteins
could recycle back to the cell surface through cycles of
ubiquitination-deubiquitination is still to be determined.
However, because the peptide displayed in the MHC-II-
binding groove can be edited by HLA-DM in endocytic
compartments, this mechanism would allow for the dis-
play of a wide variety of self peptides by the immature
DC for the induction of T cell tolerance. In contrast, both
van Niel et al. (2006) and Shin et al. (2006) report that
upon lipopolyssacharide (LPS)-induced maturation,
the amount of MHC class II ubiquitination is rapidly de-
creased. This result would explain the slow cycling rate
of MHC class II proteins on the surface of mature DCs
(Cella et al., 1997; Villadangos et al., 2001). The long-
lasting display of MHC II heterodimers loaded with anti-
genic peptides is likely needed for inducing strong T cell
immunity to pathogens. As expected, this process is
disrupted when the ubiquitinated lysine on the MHC
class II b chain is substituted with arginine in a loss-
of-function experiment. In this case, MHC class II pep-
tides are observed at the cell surface even in immature
DCs (Ohmura-Hoshino et al., 2006; van Niel et al., 2006;
Shin et al., 2006). Similarly, in a gain-of-function experi-
ment, transgenic mice were genetically engineered to
express the ubiquitin ligase c-MIR under the invariant
chain promoter (Ohmura-Hoshino et al., 2006). In these
mice, the reduction of surface MHC class II molecules is
so dramatic that their T cell development is impaired in
the thymus and the proliferative response of peripheral
CD4+ T cells weakened. Similarly, by genetically engi-
neering an MHC class II b chain with a covalently bound
ubiquitin, a forced targeting of MHC class II proteins to
endosomal compartments is observed where all MHC
class II molecules are degraded because the covalently
bound ubiquitin cannot be removed (Shin et al., 2006).
Ubiquitin is not the only molecule controlling the fate
of surface MHC class II proteins. The clathrin adaptor
complex AP-2 has also been reported to be involved
in MHC class II trafficking. The m2 subunit of the AP-2
adaptor recognizes, among others, leucine-isoleucine
targeting signals. These signals are present in position
8 and 9 on the invariant chain, whereas a single or a dou-
ble leucine is present in the b chain of MHC class II pro-
teins. Once the adaptor binds to the selected cargo,
a clathrin coat is organized around the molecules to
be transported to endosomal compartments. In imma-
ture DCs, a fraction of newly synthesized MHC class II
invariant-chain complexes transits from the trans-Golgi
network to the cell surface before rapid internalization
into endosomal compartments. This pathway has been
described by several groups, even though it is still open
to discussion whether it represents a major or a minor
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858Figure 1. Immature and Mature DC
The types of MHCII molecules found inside
multivesicular bodies (MVB) or tubular endo-
somes or on the membrane are shown. The
MVBs in the immature DC are reorganized
into tubular endosomes during maturation.
Ubiquitination sites are indicated by purple
stars. The ubiquitinated MHCII-peptide com-
plex is endocytosed. The amount on the sur-
face in the immature DC is therefore very
small. This process is inactivated during mat-
uration of the DC. In contrast, a second
mechanism for endocytosis mediated by the
AP-2 complex (shown with its four chains,
two of which have long arms) is inactivated
by caspase cleavage in immature DC, but
the inactivation process is inhibited during
maturation. Empty MHCII is present in the im-
mature state. Colored symbols represent the
mixture of peptides that is found in the pool of
MHCII peptide complexes.conduit for MHC class II trafficking. Nevertheless, MHC
class II invariant-chain complexes are present on the
surface of immature DCs. Experiments reported in van
Niel et al. (2006) indicate that ubiquitin selectively tar-
gets MHC class II loaded with antigenic peptides but
not invariant chain-loaded MHC class II heterodimers.
Because these complexes apparently are not ubiquiti-
nylated, their surface internalization must be accom-
plished through a different mechanism, likely by means
of the AP-2 adaptor. In fact, previous reports indicated
that by knocking down the AP-2 complex with siRNA,
MHC class II complexes loaded with invariant chain
are observed at the cell surface (Dugast et al., 2005;
McCormick et al., 2005; Potolicchio et al., 2005). In con-
trast, downregulation of the AP-2 adaptors does not af-
fect surface expression of peptide-empty MHC class II
proteins (Potolicchio et al., 2005).
Altogether these observations open the interesting
possibility that MHC class II molecules could have a
higher or lower affinity for ubiquitin or AP-2 adaptors
in relation to their cargo. Even though at the present
time there is not enough evidence to indicate that
ubiquitination and adaptor binding are mutually exclu-
sive, as a future direction it would be important to define
whether ubiquitin and AP-2 differently target surface
subsets of MHC class II molecules (empty, invariant
chain, or peptide loaded). If that proved to be the case,
it could be a way of manipulating the invariant-chain-de-
pendent (nascent) or -independent (recycling) pathwayof antigen presentation, the former pathway being
active in both immature and mature DC and the latter
mostly in the mature ones. Also, because MHC class II
proteins have been shown to be mono- (Ohmura-
Hoshino et al., 2006) or oligo-ubiquitinated (Ohmura-
Hoshino et al., 2006; van Niel et al., 2006; Shin et al.,
2006), a finer dissection of the ubiquitination machinery
is needed with the ultimate goal of defining whether
one or multiple ubiquitin residues would differently reg-
ulate MHC class II endosomal targeting, recycling, or
destruction.
Finally, additional mechanisms regulate MHC class II
surface expression. They include the caspase-3-medi-
ated cleavage, which is inhibited during maturation, of
AP-2 and other proteins involved in intracellular trans-
port in immature DCs (Wong et al., 2004) and tubule
formation, the mechanism of which remains to be inves-
tigated that allow for egress of MHC II complexes to the
surface in mature DC (Kleijmeer et al., 2001). In conclu-
sion, the discovery of the ubiquitin role in selectively
removing peptide-loaded MHC class II proteins from
the surface of immature DCs puts a conclusion to
the long-lasting search for why immature DCs, at the
steady state, present much fewer MHC class II peptide
complexes as compared to their mature counterpart.
Because the ubiquitin ligase c-MIR also removes B7-2
costimulatory molecule from the plasma membrane
of immature DCs (Ohmura-Hoshino et al., 2006), ubiqui-
tination may be an important process in regulating
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Homing Sweet Homing:
OdysseyofHematopoieticStemCells
The lineage relationship between the blood cells found
in the developmentally successive hematopoietic or-
gans has remained elusive. In this issue of Immunity,
Murayama et al. (2006) track the migration of nascent
hematopoietic stem cells in zebrafish from their site
of origin to a newly described intermediate location.
Shifting hematopoietic sites during embryogenesis is
a common strategy used by a wide range of divergent
species, including flies, frogs, fish, and mammals, to
allow maturation and maintenance of hematopoietic
stem cell (HSC) populations by changing the cellular
microenvironment. In vertebrates, generation of the
blood system can be separated into two phases during
development (Godin and Cumano, 2002; Mikkola and
Orkin, 2006). The first, termed primitive, is transient
and primarily produces embryonic red cells within the
blood islands of the mammalian extraembryonic yolk
sac. This wave is quickly replaced by the definitive
phase, in which adult HSCs arise de novo within the em-
bryo proper in a region termed the aorta-gonad-meso-
nephros (AGM). The subsequent hematopoietic organs,
including the fetal liver, thymus, and bone marrow, are
thought to be seeded by HSCs migrating through circu-
lation. More recently, the placenta has been shown to
be an important site of definitive hematopoiesis (Gekas
et al., 2005; Ottersbach and Dzierzak, 2005), but
whether it generates HSCs in situ or is only seeded by
circulating HSCs remains unresolved. Although limited
evidence has suggested that the HSCs colonizing the
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the AGM, direct evidence showing a lineal relationship
between these cells has been lacking.
Despite extensive evolutionary divergence between
zebrafish and mammals, the molecular pathways driv-
ing hematopoiesis and the approach of shifting anatom-
ical sites for generation of the blood system have been
highly conserved (Davidson and Zon, 2004). In this issue
of Immunity, Murayama et al. (2006) use the advantages
of the zebrafish system to describe hematopoiesis
in vivo and to show a direct lineage relationship be-
tween HSCs located in the AGM and the successive he-
matopoietic organs during larval development. Because
zebrafish embryos are generated in large numbers, are
easily accessible as a result of external fertilization,
and are optically transparent, this system is particularly
amenable to imaging-based studies that examine or-
ganogenesis in real time and to fate-mapping analyses.
Prior work has demonstrated that zebrafish undergo
both a primitive hematopoietic wave in the embryonic
lateral-plate mesoderm and a definitive phase in the
trunk dorsal aorta whereby cell types that are seemingly
equivalent to those found in the mammalian yolk sac
and AGM, respectively, are produced (Davidson and
Zon, 2004). Similar to the mouse bone marrow, the
kidney serves as the definitive site of hematopoiesis in
zebrafish; however, no intermediate hematopoietic or-
gans have previously been described. Here, the authors
visually illustrate the generation of a structure they term
the caudal hematopoietic tissue (CHT), which appears
to provide a transitional niche to support definitive HSC
expansion and maturation in the zebrafish.
Using differential interference contrast (DIC) optics
and electron mircroscopy, Murayama et al. describe
the formation of a complex vascular network generated
from a single-channel primitive caudal vein (pCV) via
angiogenesis in the tail (Figure 1). Between days 1 and
